According to Vision Research Reports, the global metagenomics market size surpassed US$ 1.2 billion in 2019 and is projected to hit US$ 6 billion by 2027.
Metagenomics is a modern genetic approach to study and analyze microbial communities from samples. This technology is used to analyze DNA extraction from environmental samples. Metagenomics is considered to be a modern approach in genetic analysis from soil, water, and other environmental samples for identification of microbes. Shotgun sequencing, 16S sequencing, and whole genome sequencing are novel metagenomics approaches used for various applications.
The global metagenomics market is driven by the rise in prevalence of genetic, infectious, and other chronic diseases across globe, novel next-generation sequencing products, wide application of metagenomics in clinical diagnosis, drug discovery, biotechnology, microbial ecology, increase in awareness about genetic disorders, and surge in investments in research & development. These factors are likely to propel the metagenomics market across the globe. North America dominated the global metagenomics market in 2019, followed by Europe & Asia Pacific. This trend is anticipated to continue during the forecast period. The region’s dominance can be ascribed to technological advancements, investments in research & development, presence of key players, increase in genetic and other chronic diseases, and adoption of metagenomic sequencing technologies.
Rise in Focus on Research & Development to Drive Global Market
The increase in research & development across the region is anticipated to develop novel molecular diagnostics to facilitate rapid diagnosis at lower costs and at greater convenience. Thus, metagenomics technologies are widely preferred as a novel approach to cater to the increasing demand for diagnostics procedures and testing. Several key players are engaged in the development of technologically advanced products and kits, and are investing in research & development by entering into strategic development such as partnerships and acquisitions. The adoption of next-generation sequencing in the analysis of complex microbial communities is a major factor that is projected to boost the market during the forecast period. For instance, MedGenome has led to the adoption of genetic diagnostics and research in India and South Asia in the past few years, which enables the company to leverage the genetic richness embedded in South Asia’s population isolates for discovery. With high-throughput data generation and analysis capabilities at scale, MedGenome is planning to partner with bio-pharma on large-scale research projects to advance personalized medicine for complex human diseases.
In February 2017, Sartorius AG entered into a partnership with EMBL, the European Molecular Biology Laboratory. EMBL is one of the Europe's leading research institutions with global reach. Thus, increase in R&D activities and expenditure for new sequencing products and therapeutics development is expected to drive the metagenomics market. Moreover, increase in investments by governments and private players in research & development for development of metagenomics approaches for drug discovery and diagnosis is anticipated to propel the market during the forecast period.
Metagenomics Sequencing Gold Standard for Diagnosis of Neuroinfectious Diseases
Metagenomics next generation sequencing is playing an instrumental role in the diagnosis of meningitis and encephalitis. The New England Journal of Medicine (NEJM) states that metagenomics sequencing is proving its utility in diagnosis of the most challenging cases of neuroinfectious diseases. Companies in the metagenomics market are increasing efforts to collect and analyze samples in real time in order to improve clinical outcomes.
A comprehensive read of the DNA and RNA in clinical samples is becoming possible with metagenomics sequencing. Companies in the metagenomics market are conducting bioinformatic comparison of the DNA and RNA samples with the publicly available databases to seek answers for agents responsible for the progression of neuroinfectious diseases. Metagenomics sequencing is being highly publicized in the healthcare landscape, since there is a high prevalence of infectious diseases that result in meningitis or encephalitis in individuals.
Drug Discovery and Soil Health Assessment Broaden Revenue Streams for Research Companies
The revenue of drug discovery is slated to witness huge leap from 22% in 2019 and reach 26% by the end of 2030 in the metagenomics market. Hence, research companies are adopting metagenomics medicine mapping systems in order to advance in the field of drug discovery. On the other hand, metagenomics is playing a pivotal role in the assessment of soil health and freshwater quality. These domains are broadening revenue streams for companies in the metagenomics market. Unprecedented environmental events and impact on the biodiversity are key drivers favoring market growth.
Prominent Regions
In terms of region, the global metagenomics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global metagenomics market in 2019, followed by Europe and Asia Pacific. The presence of key players such as Illumina Inc, technological advancements, adoption of shotgun sequencing, launch of DNA sequencer, prevalence of chronic diseases, and use of sequencing methods to diagnose diseases are a few factors that are estimated to boost the metagenomics market in the region. The metagenomics market in Europe is likely to expand at a notable CAGR from 2020 to 2030. The expansion of the market in the region can be attributed to research & development, use of metagenomics sequencing in diagnosis, and drug discovery.
According to The Community Research and Development Information Service (CORDIS), environmental DNA analyzed by metagenomics offers information on elusive or endangered species without introducing anthropogenic stress onto them. It is also useful to detect species at the early stage of invasion when found at low population densities.
Launching and Approval of Metagenomics Sequencing Products by Key Players to Drive Global Market
The global metagenomics market is consolidated in terms of number of players. The market is dominated by key players with robust geographic presence and strong product portfolio. Key players operating in the global metagenomics market include Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., Promega Corporation, Novogene Co., Ltd., Takara Bio, Inc., Oxford Nanopore Technologies, Arc Bio, LLC., Eurofins Scientific, Zymo Research, Microsynth AG, F. Hoffmann-La Roche Ltd. (Roche Sequencing), PerkinElmer, Inc., and Computomics GmbH. On March 03, 2020, Thermo Fisher Scientific, Inc. and QIAGEN N.V. announced that the board of directors, as well as the managing board of QIAGEN N.V. have unanimously approved Thermo Fisher’s proposal to acquire QIAGEN.
On January 5, 2017, CosmosID developed an automated metagenomics analysis solution and launched its Metagenomic and Antibiotic Resistance Application on the Thermo Fisher Cloud platform.
Market Segmentation
By Product Type
By Technology
By Application
By Region
Scope of the Report
VRR’s report on the global metagenomics market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period, 2020 to 2027. The report provides the overall revenue of the global metagenomics market for the period 2016–2027, considering 2020 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global metagenomics market for the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global metagenomics market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global metagenomics market.
The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global metagenomics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global metagenomics market. The next section of the global metagenomics market report highlights the USPs, which include key industry events and developments, major research institutes involved, pricing analysis, technological advancements, and COVID-19 pandemic impact on global metagenomics market
The report delves into the competition landscape of the global metagenomics market. Key players operating in the global metagenomics market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global metagenomics market report.
Key Questions Answered in Metagenomics Market Report
Research Objectives and Research Approach
The comprehensive report on the global metagenomics market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global metagenomics market. It is followed by market introduction, market dynamics, and an overview of the global metagenomics market, which includes VRR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the metagenomics market. The next section of the global metagenomics market report highlights the USPs, which include key industry events and developments, major research institutes involved, pricing analysis, technological advancements and COVID-19 pandemic impact on global metagenomics market
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Revenue generated by key metagenomics technology and products manufacturers has been mapped to ascertain the size of the global metagenomics market in terms of value. The forecast presented here assesses the total revenue generated in the metagenomics market. In order to provide an accurate forecast, we initiated by sizing up the current metagenomics market with the help of the parent market.
The report analyzes the global metagenomics market in terms of product type, technology, application, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global metagenomics market.
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers